Tratamento clínico da doença coronariana multiarterial estável. Menos é mais? / Medical therapy of stable multivessel coronary artery disease: less is more?
Int. j. cardiovasc. sci. (Impr.)
;
28(2): 160-162, mar.-abr. 2015.
Article
in English, Portuguese
| LILACS
| ID: lil-762458
RESUMO
Apesar dos avanços de todas as formas de tratamento da doença arterial coronariana (DAC) estável, ainda háconsiderável controvérsia sobre as vantagens da revascularização miocárdica em comparação com o tratamento clínico (TC) contemporâneo. Na DAC multiarterial, os ensaios clínicos randomizados demonstraram que astécnicas de revascularização não reduziram a incidência de desfechos duros, como morte e infarto agudo domiocárdio não fatal. Desse modo, esses estudos sugerem que o TC, tratamento de menor custo, possa ser aplicadocomo terapia inicial nesses pacientes.
ABSTRACT
Despite the advances of all forms of treatment of stable coronary artery disease (CAD), there is still considerable controversy about the benefits of myocardial revascularization compared with medical therapy (CT). In multivessel CAD, randomized clinicaltrials have demonstrated that revascularization techniques did not reduce the incidence of hard outcomes, such as death and acute nonfatal myocardial infarction. Thus, these studies suggest that CT, lower cost treatment, may be applied as initial therapy for these patients.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Homeopathic Therapeutic Approaches
/
Coronary Disease
/
Myocardial Revascularization
Type of study:
Controlled clinical trial
/
Diagnostic study
Limits:
Humans
Language:
English
/
Portuguese
Journal:
Int. j. cardiovasc. sci. (Impr.)
Journal subject:
Cardiology
Year:
2015
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Pró-Cardíaco/BR
Similar
MEDLINE
...
LILACS
LIS